CP
Caligan Partners LP disclosed a 6.2% stake in IRD
Caligan Partners LP reported owning 6.2% of Opus Genetics, Inc. (IRD) (5,960,972 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.